Hologic Wins Patent Battle Over Breast Cancer Detection Tech Against Siemens
Hologic announced a court ruling in its favor over a patent dispute with Siemens. The case centered on technology used for detecting breast cancer. A
Hologic announced a court ruling in its favor over a patent dispute with
Siemens. The case centered on technology used for detecting breast cancer. A
judge affirmed Hologic’s ownership of the contested patents. Siemens was ordered
to cease using the disputed technology. The decision strengthens Hologic’s
market position in breast health diagnostics. It may limit Siemens’ ability to
offer competing detection solutions. Industry analysts view the ruling as a
significant win for Hologic’s IP portfolio. The outcome could influence future
litigation in medical device patents.